Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Archives of Biochemistry and Biophysics|January 11, 2012
Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding propertiesMichelle C Vendel, Michael Favis, William B Snyder, et al.
Journal of Neurosurgery. Spine|May 26, 2018
Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?Ronny Kalash, Scott M Glaser, John C Flickinger, et al.
Proteins|December 18, 2008
Conserved amino acid networks involved in antibody variable domain interactionsNorman Wang, William F Smith, Brian R Miller, et al.
In Vivo (Athens, Greece)|December 25, 2017
Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate CancerScott M Glaser, Ronny Kalash, Dante R Bongiorni, et al.
Frontiers in Oncology|February 8, 2017
Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung CancerMark E Bernard, Scott M Glaser, Beant S Gill, et al.
Gynecologic Oncology|January 27, 2021
Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancerSarah Ashmore, Sarah M Crafton, Eirwen M Miller, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2019
Early mortality of stage IV non-small cell lung cancer in the United StatesArya Amini, Vivek Verma, Scott M Glaser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2018
Rising Rates of Upfront Surgery in Early Locally Advanced Cervical Cancer: What Factors Predict for This Treatment Paradigm?Arya Amini, Tyler P Robin, Priscilla K Stumpf, et al.
American Journal of Clinical Oncology|June 12, 2018
Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical CancerArya Amini, Tyler P Robin, Chad G Rusthoven, et al.
Protein Engineering, Design & Selection : PEDS|May 12, 2010
Stability engineering of scFvs for the development of bispecific and multivalent antibodiesBrian R Miller, Stephen J Demarest, Alexey Lugovskoy, et al.
Pageof 6